The inflammatory tumor microenvironment and its impact on cancer development.
暂无分享,去创建一个
[1] D. McDonald,et al. Significance of blood vessel leakiness in cancer. , 2002, Cancer research.
[2] A. Luster. The role of chemokines in linking innate and adaptive immunity. , 2002, Current opinion in immunology.
[3] G. Dranoff. Coordinated tumor immunity , 2003 .
[4] B. Levin,et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.
[5] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[6] F. Balkwill. Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.
[7] Kristian Pietras,et al. High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.
[8] F. Belardelli,et al. Cytokines as a link between innate and adaptive antitumor immunity. , 2002, Trends in immunology.
[9] D. Hanahan,et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.
[10] B. Fingleton,et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.
[11] S. Cingarlini,et al. Derangement of immune responses by myeloid suppressor cells , 2004, Cancer Immunology, Immunotherapy.
[12] S. Aulmann,et al. Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2. , 2005, The American journal of pathology.
[13] T. Kupper,et al. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. , 2000, The Journal of investigative dermatology.
[14] M. Herlyn,et al. Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1 , 2001, The Journal of Immunology.
[15] C. June,et al. Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1 , 2002, The Journal of Immunology.
[16] H. Adami,et al. Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.
[17] Hans Clevers,et al. At the Crossroads of Inflammation and Cancer , 2004, Cell.
[18] M. Thun,et al. Inflammation and cancer: an epidemiological perspective. , 2004, Novartis Foundation symposium.
[19] Y. Matsuzaki,et al. Effect of mast cells on tumor angiogenesis in lung cancer. , 2000, The Annals of thoracic surgery.
[20] L. Coussens,et al. Extrinsic regulators of epithelial tumor progression: metalloproteinases. , 2000, Current opinion in genetics & development.
[21] L. Staudt,et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.
[22] T. Koike,et al. The polymorphism interleukin 8 −251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population , 2005, Gut.
[23] H. Macdonald,et al. The Early IL-4 Response to Leishmania major and the Resulting Th2 Cell Maturation Steering Progressive Disease in BALB/c Mice Are Subject to the Control of Regulatory CD4+CD25+ T Cells1 , 2002, The Journal of Immunology.
[24] L. Coussens,et al. Early neoplastic progression is complement independent. , 2004, Neoplasia.
[25] G. Friedman,et al. Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.
[26] N. Funel,et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma , 2004, Journal of Clinical Pathology.
[27] T. Schumacher,et al. CD8+ T Cell Tolerance and Cancer Immunotherapy , 2003, Journal of immunotherapy.
[28] D. Hanahan,et al. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. , 1996, The American journal of pathology.
[29] J. Ferlay,et al. Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[30] P. Maisonneuve,et al. Chronic Pancreatitis and Pancreatic Cancer , 2002, Digestive Diseases.
[31] S. Tonegawa. Somatic generation of antibody diversity , 1983, Nature.
[32] S. Stacker,et al. Focus on lymphangiogenesis in tumor metastasis. , 2005, Cancer cell.
[33] L. Coussens,et al. Cancer: An inflammatory link , 2004, Nature.
[34] I. Fidler,et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.
[35] S. Okushiba,et al. Long-term survival after radical resection of advanced pancreatic cancer , 2003, International journal of gastrointestinal cancer.
[36] I. Wistuba,et al. Gallbladder cancer: lessons from a rare tumour , 2004, Nature Reviews Cancer.
[37] Nigel J. Saunders,et al. CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms , 2003, The Journal of experimental medicine.
[38] J. Pollard,et al. Macrophages: modulators of breast cancer progression. , 2004, Novartis Foundation symposium.
[39] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[40] J. Sprent,et al. T cell memory. , 2003, Annual review of immunology.
[41] H. Ohtani,et al. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis , 2004, British Journal of Cancer.
[42] B. Gold,et al. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. , 2000, Annual review of microbiology.
[43] Shu-Hsia Chen,et al. Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation1 , 2000, The Journal of Immunology.
[44] S. Takeno,et al. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. , 2003, Oncology reports.
[45] F. Balkwill. Cancer and the chemokine network , 2004, Nature Reviews Cancer.
[46] P. Ernst,et al. Review article: the role of inflammation in the pathogenesis of gastric cancer , 1999, Alimentary pharmacology & therapeutics.
[47] George Coukos,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.
[48] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[49] S. Sakaguchi. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.
[50] P Boffetta,et al. A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.
[51] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[52] H. Choy,et al. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? , 2003, Journal of the National Cancer Institute.
[53] O. Finn,et al. Cancer vaccines: between the idea and the reality , 2003, Nature Reviews Immunology.
[54] Silvano Sozzani,et al. The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.
[55] D. Hanahan,et al. Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells , 2003, The Journal of experimental medicine.
[56] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[57] T. Oshikiri,et al. Clinical significance of immune cell infiltration within gallbladder cancer , 2003, British Journal of Cancer.
[58] Koichi Yamazaki,et al. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non‐small cell lung cancers , 2003, Cancer science.
[59] R. Ness,et al. Possible role of ovarian epithelial inflammation in ovarian cancer. , 1999, Journal of the National Cancer Institute.
[60] Steven A. Rosenberg,et al. Adoptive-cell-transfer therapy for the treatment of patients with cancer , 2003, Nature Reviews Cancer.
[61] R. DuBois,et al. Cyclooxygenase‐2 and Gastrointestinal Cancer , 2004, Cancer journal.
[62] Olivier De Wever,et al. Role of tissue stroma in cancer cell invasion , 2003, The Journal of pathology.
[63] H. Kojima,et al. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. , 2000, The European respiratory journal.
[64] L. Norton,et al. Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer , 2002, The Journal of Biological Chemistry.
[65] L. Coussens,et al. Inflammation and cancer , 2002, Nature.
[66] E. Heathcote,et al. Prevention of hepatitis C virus-related hepatocellular carcinoma. , 2004, Gastroenterology.
[67] A. Mantovani,et al. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.
[68] Blossom Damania,et al. Infectious agents and cancer: criteria for a causal relation. , 2004, Seminars in cancer biology.
[69] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[70] B. Evers,et al. Inflammation and the development of pancreatic cancer. , 2002, Surgical oncology.
[71] J. Masferrer,et al. Celecoxib: a specific COX-2 inhibitor with anticancer properties. , 2002, Cancer control : journal of the Moffitt Cancer Center.
[72] N. Restifo,et al. Creating therapeutic cancer vaccines: notes from the battlefield. , 2001, Trends in immunology.
[73] P. Allavena,et al. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. , 2004, European journal of cancer.
[74] J. Okamura,et al. Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis , 1999, Gastric Cancer.
[75] S. Piantadosi,et al. Primary chemoprevention of familial adenomatous polyposis with sulindac , 2002 .
[76] T. Tlsty,et al. Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.
[77] H. Maeda,et al. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. , 1998, Biochemistry. Biokhimiia.
[78] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[79] G. Gasparini,et al. Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? , 2003, The Lancet. Oncology.
[80] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[81] H. Nagai,et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. , 1998, Gastroenterology.
[82] I. Takanami,et al. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma , 2000, Cancer.
[83] Michael Karin,et al. IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.
[84] S. Jimi,et al. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. , 2000, Human pathology.
[85] R. DuBois,et al. COX-2 inhibition and colorectal cancer. , 2004, Seminars in oncology.
[86] T. Hla,et al. Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice* , 2001, The Journal of Biological Chemistry.
[87] L. Benítez-Bribiesca,et al. The Role of Mast Cell Tryptase in Neoangiogenesis of Premalignant and Malignant Lesions of the Uterine Cervix , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[88] Masahiro Inoue,et al. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.
[89] J. Nyhus,et al. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. , 2002, Cancer research.
[90] D. Forman,et al. An international association between Helicobacter pylori infection and gastric cancer , 1993 .
[91] T. Fujioka,et al. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. , 1998, Cancer research.
[92] K. Seibert,et al. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. , 2000, Cancer research.
[93] L. A. Richards,et al. Increased mast cell density in invasive melanoma , 1998, Journal of cutaneous pathology.
[94] D. Gabrilovich,et al. Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells1 , 2001, The Journal of Immunology.
[95] Shigeyoshi Itohara,et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.
[96] D. Gabrilovich,et al. Immature myeloid cells and cancer-associated immune suppression , 2002, Cancer Immunology, Immunotherapy.
[97] H. Jick,et al. Association Between Acetaminophen or Nonsteroidal Antiinflammatory Drugs and Risk of Developing Ovarian, Breast, or Colon Cancer , 2002, Pharmacotherapy.
[98] Christian Bréchot,et al. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. , 2004, Gastroenterology.
[99] T. Oshikiri,et al. Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response , 2003, Journal of surgical oncology.
[100] Yasmine Belkaid,et al. Natural regulatory T cells in infectious disease , 2005, Nature Immunology.
[101] L. Coussens,et al. Inflammation and matrix metalloproteinases: implications for cancer development , 2004 .
[102] S. Prescott,et al. Many actions of cyclooxygenase‐2 in cellular dynamics and in cancer , 2002, Journal of cellular physiology.
[103] L. Coussens,et al. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. , 2005, Cancer cell.
[104] F. Chisari,et al. Immune Pathogenesis of Hepatocellular Carcinoma , 1998, The Journal of experimental medicine.
[105] S. Weitzman,et al. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. , 1990, Blood.
[106] D. Whitcomb. Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[107] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[108] A. De Luca,et al. Helicobacter pylori and gastric diseases: a dangerous association. , 2004, Cancer letters.
[109] Charles A. Janeway,et al. INAUGURAL ARTICLE by a Recently Elected Academy Member:How the immune system works to protect the host from infection: A personal view , 2001 .
[110] C. López-Otín,et al. Protease degradomics: A new challenge for proteomics , 2002, Nature Reviews Molecular Cell Biology.
[111] A. Sabichi,et al. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression. , 2005, Cancer research.
[112] R. DuBois,et al. Cyclooxygenase-2: a therapeutic target. , 2002, Annual review of medicine.
[113] X. Puente,et al. Human and mouse proteases: a comparative genomic approach , 2003, Nature Reviews Genetics.
[114] L. Hansson,et al. Aspirin and risk for gastric cancer: a population-based case–control study in Sweden , 2001, British Journal of Cancer.
[115] J. Renauld. New insights into the role of cytokines in asthma , 2001, Journal of clinical pathology.
[116] D. Hanahan,et al. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice , 1994, Journal of virology.
[117] A. Lindgren,et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.
[118] V. Bronte,et al. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. , 2003, Trends in immunology.
[119] J. Isola,et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. , 2002, Cancer research.
[120] K. Abrams,et al. The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.
[121] S. Weitzman,et al. Chronic inflammation and cancer. , 2002, Oncology.
[122] H. Ohshima. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. , 2003, Toxicology letters.
[123] J A Hanley,et al. Nested caseÐcontrol study of the effects of non- steroidal anti-inflammatory drugs on breast cancer risk and stage , 2000 .
[124] L. Matrisian,et al. Matrix metalloproteinases: they're not just for matrix anymore! , 2001, Current opinion in cell biology.
[125] D. Bar-Sagi,et al. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.
[126] Toru Watanabe,et al. Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. , 2002, Anticancer research.
[127] M. Cotterchio,et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[128] M. Bevan,et al. Selecting and maintaining a diverse T-cell repertoire , 1999, Nature.
[129] George Coukos,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.
[130] M. McHeyzer-Williams,et al. B cells as effectors. , 2003, Current opinion in immunology.
[131] W. Schürch,et al. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[132] F. Marks,et al. Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[133] M. Fernández-arquero,et al. Interleukin-10 polymorphisms in Spanish type 1 diabetes patients , 2004, Genes and Immunity.
[134] D. Pardoll,et al. Does the immune system see tumors as foreign or self? , 2003, Annual review of immunology.
[135] Nicholas R. English,et al. Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer1 , 2001, The Journal of Immunology.
[136] Xianglin Shi,et al. Diseases caused by silica: mechanisms of injury and disease development. , 2002, International immunopharmacology.
[137] R. Ronca,et al. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. , 2000, Blood.
[138] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.
[139] M. Carroll,et al. The complement system in regulation of adaptive immunity , 2004, Nature Immunology.
[140] L. G. García Rodríguez,et al. Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs , 2001, Epidemiology.
[141] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[142] S. Rosenberg,et al. Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.
[143] J. Demengeot,et al. CD25+CD4+ regulatory T cells suppress CD4+ T cell‐mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice , 2002 .
[144] G. Forni,et al. Immunological inhibition of carcinogenesis , 2004, Cancer Immunology, Immunotherapy.